Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FMYAN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $47,145
Award facts
- Contract value 100% obligated
- $47,145.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Dupixent 300 mg/2 mL pen injectors with a firm fixed price ceiling value of $47,145.15 and ultimate completion date of August 18, 2025. This competitive award includes no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and established critical vendor for federal medical procurement serving military and veteran healthcare systems.
Dupixent (dupilumab) is a biologic medication indicated for moderate-to-severe atopic dermatitis, asthma, and eosinophilic conditions, representing the type of specialized pharmaceutical inventory that AmerisourceBergen supplies through its comprehensive DLA contract. The pharmaceutical prime vendor arrangement enables AmerisourceBergen to fulfill federal medical supply needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the company's capability to support military healthcare programs through firm fixed-price procurement mechanisms while competing in an open, non-set-aside process.
Quick answers
Who was awarded contract SPE2DB25FMYAN?
SPE2DB25FMYAN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 15, 2025.
How much is contract SPE2DB25FMYAN worth?
The government has obligated $47,145 on SPE2DB25FMYAN.
Is contract SPE2DB25FMYAN an order under another contract?
Yes. SPE2DB25FMYAN is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMYAN competed?
The extent of competition for SPE2DB25FMYAN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award